Global Solid Dosage Form Drug Supply, Demand and Key Producers, 2023-2029
The global Solid Dosage Form Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
This report studies the global Solid Dosage Form Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Solid Dosage Form Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Solid Dosage Form Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Solid Dosage Form Drug total market, 2018-2029, (USD Million)
Global Solid Dosage Form Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Solid Dosage Form Drug total market, key domestic companies and share, (USD Million)
Global Solid Dosage Form Drug revenue by player and market share 2018-2023, (USD Million)
Global Solid Dosage Form Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Solid Dosage Form Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Solid Dosage Form Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Solid Dosage Form Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Solid Dosage Form Drug Market, By Region:
1. How big is the global Solid Dosage Form Drug market?
2. What is the demand of the global Solid Dosage Form Drug market?
3. What is the year over year growth of the global Solid Dosage Form Drug market?
4. What is the total value of the global Solid Dosage Form Drug market?
5. Who are the major players in the global Solid Dosage Form Drug market?
6. What are the growth factors driving the market demand?
Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
This report studies the global Solid Dosage Form Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Solid Dosage Form Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Solid Dosage Form Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Solid Dosage Form Drug total market, 2018-2029, (USD Million)
Global Solid Dosage Form Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Solid Dosage Form Drug total market, key domestic companies and share, (USD Million)
Global Solid Dosage Form Drug revenue by player and market share 2018-2023, (USD Million)
Global Solid Dosage Form Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Solid Dosage Form Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Solid Dosage Form Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Solid Dosage Form Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Solid Dosage Form Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tablet
- Capsules
- Other
- Hospital
- Retail Pharmacy
- Other
- Johnson & Johnson
- Novartis
- Roche
- AbbVie
- Merck & Co.
- Bristol Myers Squibb
- GlaxoSmithKline
- Pfizer
- Sanofi
- Takeda
- AstraZeneca
- Bayer
- Eli Lilly & Co.
- Gilead Sciences
- Amgen
- Teva
- Boehringer Ingelheim
- Biogen
- Astellas
1. How big is the global Solid Dosage Form Drug market?
2. What is the demand of the global Solid Dosage Form Drug market?
3. What is the year over year growth of the global Solid Dosage Form Drug market?
4. What is the total value of the global Solid Dosage Form Drug market?
5. Who are the major players in the global Solid Dosage Form Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Solid Dosage Form Drug Introduction
1.2 World Solid Dosage Form Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Solid Dosage Form Drug Total Market by Region (by Headquarter Location)
1.3.1 World Solid Dosage Form Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Solid Dosage Form Drug Market Size (2018-2029)
1.3.3 China Solid Dosage Form Drug Market Size (2018-2029)
1.3.4 Europe Solid Dosage Form Drug Market Size (2018-2029)
1.3.5 Japan Solid Dosage Form Drug Market Size (2018-2029)
1.3.6 South Korea Solid Dosage Form Drug Market Size (2018-2029)
1.3.7 ASEAN Solid Dosage Form Drug Market Size (2018-2029)
1.3.8 India Solid Dosage Form Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Solid Dosage Form Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Solid Dosage Form Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Solid Dosage Form Drug Consumption Value (2018-2029)
2.2 World Solid Dosage Form Drug Consumption Value by Region
2.2.1 World Solid Dosage Form Drug Consumption Value by Region (2018-2023)
2.2.2 World Solid Dosage Form Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Solid Dosage Form Drug Consumption Value (2018-2029)
2.4 China Solid Dosage Form Drug Consumption Value (2018-2029)
2.5 Europe Solid Dosage Form Drug Consumption Value (2018-2029)
2.6 Japan Solid Dosage Form Drug Consumption Value (2018-2029)
2.7 South Korea Solid Dosage Form Drug Consumption Value (2018-2029)
2.8 ASEAN Solid Dosage Form Drug Consumption Value (2018-2029)
2.9 India Solid Dosage Form Drug Consumption Value (2018-2029)
3 WORLD SOLID DOSAGE FORM DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Solid Dosage Form Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Solid Dosage Form Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Solid Dosage Form Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Solid Dosage Form Drug in 2022
3.3 Solid Dosage Form Drug Company Evaluation Quadrant
3.4 Solid Dosage Form Drug Market: Overall Company Footprint Analysis
3.4.1 Solid Dosage Form Drug Market: Region Footprint
3.4.2 Solid Dosage Form Drug Market: Company Product Type Footprint
3.4.3 Solid Dosage Form Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Solid Dosage Form Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Solid Dosage Form Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Solid Dosage Form Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Solid Dosage Form Drug Consumption Value Comparison
4.2.1 United States VS China: Solid Dosage Form Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Solid Dosage Form Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Solid Dosage Form Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Solid Dosage Form Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Solid Dosage Form Drug Revenue, (2018-2023)
4.4 China Based Companies Solid Dosage Form Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Solid Dosage Form Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Solid Dosage Form Drug Revenue, (2018-2023)
4.5 Rest of World Based Solid Dosage Form Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Solid Dosage Form Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Solid Dosage Form Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Solid Dosage Form Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tablet
5.2.2 Capsules
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Solid Dosage Form Drug Market Size by Type (2018-2023)
5.3.2 World Solid Dosage Form Drug Market Size by Type (2024-2029)
5.3.3 World Solid Dosage Form Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Solid Dosage Form Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Solid Dosage Form Drug Market Size by Application (2018-2023)
6.3.2 World Solid Dosage Form Drug Market Size by Application (2024-2029)
6.3.3 World Solid Dosage Form Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Details
7.1.2 Johnson & Johnson Major Business
7.1.3 Johnson & Johnson Solid Dosage Form Drug Product and Services
7.1.4 Johnson & Johnson Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Johnson & Johnson Recent Developments/Updates
7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Solid Dosage Form Drug Product and Services
7.2.4 Novartis Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche Solid Dosage Form Drug Product and Services
7.3.4 Roche Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 AbbVie
7.4.1 AbbVie Details
7.4.2 AbbVie Major Business
7.4.3 AbbVie Solid Dosage Form Drug Product and Services
7.4.4 AbbVie Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 AbbVie Recent Developments/Updates
7.4.6 AbbVie Competitive Strengths & Weaknesses
7.5 Merck & Co.
7.5.1 Merck & Co. Details
7.5.2 Merck & Co. Major Business
7.5.3 Merck & Co. Solid Dosage Form Drug Product and Services
7.5.4 Merck & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Merck & Co. Recent Developments/Updates
7.5.6 Merck & Co. Competitive Strengths & Weaknesses
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Details
7.6.2 Bristol Myers Squibb Major Business
7.6.3 Bristol Myers Squibb Solid Dosage Form Drug Product and Services
7.6.4 Bristol Myers Squibb Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol Myers Squibb Recent Developments/Updates
7.6.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Details
7.7.2 GlaxoSmithKline Major Business
7.7.3 GlaxoSmithKline Solid Dosage Form Drug Product and Services
7.7.4 GlaxoSmithKline Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 GlaxoSmithKline Recent Developments/Updates
7.7.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Solid Dosage Form Drug Product and Services
7.8.4 Pfizer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 Sanofi
7.9.1 Sanofi Details
7.9.2 Sanofi Major Business
7.9.3 Sanofi Solid Dosage Form Drug Product and Services
7.9.4 Sanofi Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Sanofi Recent Developments/Updates
7.9.6 Sanofi Competitive Strengths & Weaknesses
7.10 Takeda
7.10.1 Takeda Details
7.10.2 Takeda Major Business
7.10.3 Takeda Solid Dosage Form Drug Product and Services
7.10.4 Takeda Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Takeda Recent Developments/Updates
7.10.6 Takeda Competitive Strengths & Weaknesses
7.11 AstraZeneca
7.11.1 AstraZeneca Details
7.11.2 AstraZeneca Major Business
7.11.3 AstraZeneca Solid Dosage Form Drug Product and Services
7.11.4 AstraZeneca Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 AstraZeneca Recent Developments/Updates
7.11.6 AstraZeneca Competitive Strengths & Weaknesses
7.12 Bayer
7.12.1 Bayer Details
7.12.2 Bayer Major Business
7.12.3 Bayer Solid Dosage Form Drug Product and Services
7.12.4 Bayer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Bayer Recent Developments/Updates
7.12.6 Bayer Competitive Strengths & Weaknesses
7.13 Eli Lilly & Co.
7.13.1 Eli Lilly & Co. Details
7.13.2 Eli Lilly & Co. Major Business
7.13.3 Eli Lilly & Co. Solid Dosage Form Drug Product and Services
7.13.4 Eli Lilly & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Eli Lilly & Co. Recent Developments/Updates
7.13.6 Eli Lilly & Co. Competitive Strengths & Weaknesses
7.14 Gilead Sciences
7.14.1 Gilead Sciences Details
7.14.2 Gilead Sciences Major Business
7.14.3 Gilead Sciences Solid Dosage Form Drug Product and Services
7.14.4 Gilead Sciences Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Gilead Sciences Recent Developments/Updates
7.14.6 Gilead Sciences Competitive Strengths & Weaknesses
7.15 Amgen
7.15.1 Amgen Details
7.15.2 Amgen Major Business
7.15.3 Amgen Solid Dosage Form Drug Product and Services
7.15.4 Amgen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Amgen Recent Developments/Updates
7.15.6 Amgen Competitive Strengths & Weaknesses
7.16 Teva
7.16.1 Teva Details
7.16.2 Teva Major Business
7.16.3 Teva Solid Dosage Form Drug Product and Services
7.16.4 Teva Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Teva Recent Developments/Updates
7.16.6 Teva Competitive Strengths & Weaknesses
7.17 Boehringer Ingelheim
7.17.1 Boehringer Ingelheim Details
7.17.2 Boehringer Ingelheim Major Business
7.17.3 Boehringer Ingelheim Solid Dosage Form Drug Product and Services
7.17.4 Boehringer Ingelheim Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Boehringer Ingelheim Recent Developments/Updates
7.17.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.18 Biogen
7.18.1 Biogen Details
7.18.2 Biogen Major Business
7.18.3 Biogen Solid Dosage Form Drug Product and Services
7.18.4 Biogen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Biogen Recent Developments/Updates
7.18.6 Biogen Competitive Strengths & Weaknesses
7.19 Astellas
7.19.1 Astellas Details
7.19.2 Astellas Major Business
7.19.3 Astellas Solid Dosage Form Drug Product and Services
7.19.4 Astellas Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Astellas Recent Developments/Updates
7.19.6 Astellas Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Solid Dosage Form Drug Industry Chain
8.2 Solid Dosage Form Drug Upstream Analysis
8.3 Solid Dosage Form Drug Midstream Analysis
8.4 Solid Dosage Form Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Solid Dosage Form Drug Introduction
1.2 World Solid Dosage Form Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Solid Dosage Form Drug Total Market by Region (by Headquarter Location)
1.3.1 World Solid Dosage Form Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Solid Dosage Form Drug Market Size (2018-2029)
1.3.3 China Solid Dosage Form Drug Market Size (2018-2029)
1.3.4 Europe Solid Dosage Form Drug Market Size (2018-2029)
1.3.5 Japan Solid Dosage Form Drug Market Size (2018-2029)
1.3.6 South Korea Solid Dosage Form Drug Market Size (2018-2029)
1.3.7 ASEAN Solid Dosage Form Drug Market Size (2018-2029)
1.3.8 India Solid Dosage Form Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Solid Dosage Form Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Solid Dosage Form Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Solid Dosage Form Drug Consumption Value (2018-2029)
2.2 World Solid Dosage Form Drug Consumption Value by Region
2.2.1 World Solid Dosage Form Drug Consumption Value by Region (2018-2023)
2.2.2 World Solid Dosage Form Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Solid Dosage Form Drug Consumption Value (2018-2029)
2.4 China Solid Dosage Form Drug Consumption Value (2018-2029)
2.5 Europe Solid Dosage Form Drug Consumption Value (2018-2029)
2.6 Japan Solid Dosage Form Drug Consumption Value (2018-2029)
2.7 South Korea Solid Dosage Form Drug Consumption Value (2018-2029)
2.8 ASEAN Solid Dosage Form Drug Consumption Value (2018-2029)
2.9 India Solid Dosage Form Drug Consumption Value (2018-2029)
3 WORLD SOLID DOSAGE FORM DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Solid Dosage Form Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Solid Dosage Form Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Solid Dosage Form Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Solid Dosage Form Drug in 2022
3.3 Solid Dosage Form Drug Company Evaluation Quadrant
3.4 Solid Dosage Form Drug Market: Overall Company Footprint Analysis
3.4.1 Solid Dosage Form Drug Market: Region Footprint
3.4.2 Solid Dosage Form Drug Market: Company Product Type Footprint
3.4.3 Solid Dosage Form Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Solid Dosage Form Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Solid Dosage Form Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Solid Dosage Form Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Solid Dosage Form Drug Consumption Value Comparison
4.2.1 United States VS China: Solid Dosage Form Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Solid Dosage Form Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Solid Dosage Form Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Solid Dosage Form Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Solid Dosage Form Drug Revenue, (2018-2023)
4.4 China Based Companies Solid Dosage Form Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Solid Dosage Form Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Solid Dosage Form Drug Revenue, (2018-2023)
4.5 Rest of World Based Solid Dosage Form Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Solid Dosage Form Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Solid Dosage Form Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Solid Dosage Form Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tablet
5.2.2 Capsules
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Solid Dosage Form Drug Market Size by Type (2018-2023)
5.3.2 World Solid Dosage Form Drug Market Size by Type (2024-2029)
5.3.3 World Solid Dosage Form Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Solid Dosage Form Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Solid Dosage Form Drug Market Size by Application (2018-2023)
6.3.2 World Solid Dosage Form Drug Market Size by Application (2024-2029)
6.3.3 World Solid Dosage Form Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Details
7.1.2 Johnson & Johnson Major Business
7.1.3 Johnson & Johnson Solid Dosage Form Drug Product and Services
7.1.4 Johnson & Johnson Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Johnson & Johnson Recent Developments/Updates
7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Solid Dosage Form Drug Product and Services
7.2.4 Novartis Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Roche
7.3.1 Roche Details
7.3.2 Roche Major Business
7.3.3 Roche Solid Dosage Form Drug Product and Services
7.3.4 Roche Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Roche Recent Developments/Updates
7.3.6 Roche Competitive Strengths & Weaknesses
7.4 AbbVie
7.4.1 AbbVie Details
7.4.2 AbbVie Major Business
7.4.3 AbbVie Solid Dosage Form Drug Product and Services
7.4.4 AbbVie Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 AbbVie Recent Developments/Updates
7.4.6 AbbVie Competitive Strengths & Weaknesses
7.5 Merck & Co.
7.5.1 Merck & Co. Details
7.5.2 Merck & Co. Major Business
7.5.3 Merck & Co. Solid Dosage Form Drug Product and Services
7.5.4 Merck & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Merck & Co. Recent Developments/Updates
7.5.6 Merck & Co. Competitive Strengths & Weaknesses
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Details
7.6.2 Bristol Myers Squibb Major Business
7.6.3 Bristol Myers Squibb Solid Dosage Form Drug Product and Services
7.6.4 Bristol Myers Squibb Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol Myers Squibb Recent Developments/Updates
7.6.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Details
7.7.2 GlaxoSmithKline Major Business
7.7.3 GlaxoSmithKline Solid Dosage Form Drug Product and Services
7.7.4 GlaxoSmithKline Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 GlaxoSmithKline Recent Developments/Updates
7.7.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Solid Dosage Form Drug Product and Services
7.8.4 Pfizer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 Sanofi
7.9.1 Sanofi Details
7.9.2 Sanofi Major Business
7.9.3 Sanofi Solid Dosage Form Drug Product and Services
7.9.4 Sanofi Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Sanofi Recent Developments/Updates
7.9.6 Sanofi Competitive Strengths & Weaknesses
7.10 Takeda
7.10.1 Takeda Details
7.10.2 Takeda Major Business
7.10.3 Takeda Solid Dosage Form Drug Product and Services
7.10.4 Takeda Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Takeda Recent Developments/Updates
7.10.6 Takeda Competitive Strengths & Weaknesses
7.11 AstraZeneca
7.11.1 AstraZeneca Details
7.11.2 AstraZeneca Major Business
7.11.3 AstraZeneca Solid Dosage Form Drug Product and Services
7.11.4 AstraZeneca Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 AstraZeneca Recent Developments/Updates
7.11.6 AstraZeneca Competitive Strengths & Weaknesses
7.12 Bayer
7.12.1 Bayer Details
7.12.2 Bayer Major Business
7.12.3 Bayer Solid Dosage Form Drug Product and Services
7.12.4 Bayer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Bayer Recent Developments/Updates
7.12.6 Bayer Competitive Strengths & Weaknesses
7.13 Eli Lilly & Co.
7.13.1 Eli Lilly & Co. Details
7.13.2 Eli Lilly & Co. Major Business
7.13.3 Eli Lilly & Co. Solid Dosage Form Drug Product and Services
7.13.4 Eli Lilly & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Eli Lilly & Co. Recent Developments/Updates
7.13.6 Eli Lilly & Co. Competitive Strengths & Weaknesses
7.14 Gilead Sciences
7.14.1 Gilead Sciences Details
7.14.2 Gilead Sciences Major Business
7.14.3 Gilead Sciences Solid Dosage Form Drug Product and Services
7.14.4 Gilead Sciences Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Gilead Sciences Recent Developments/Updates
7.14.6 Gilead Sciences Competitive Strengths & Weaknesses
7.15 Amgen
7.15.1 Amgen Details
7.15.2 Amgen Major Business
7.15.3 Amgen Solid Dosage Form Drug Product and Services
7.15.4 Amgen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Amgen Recent Developments/Updates
7.15.6 Amgen Competitive Strengths & Weaknesses
7.16 Teva
7.16.1 Teva Details
7.16.2 Teva Major Business
7.16.3 Teva Solid Dosage Form Drug Product and Services
7.16.4 Teva Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Teva Recent Developments/Updates
7.16.6 Teva Competitive Strengths & Weaknesses
7.17 Boehringer Ingelheim
7.17.1 Boehringer Ingelheim Details
7.17.2 Boehringer Ingelheim Major Business
7.17.3 Boehringer Ingelheim Solid Dosage Form Drug Product and Services
7.17.4 Boehringer Ingelheim Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Boehringer Ingelheim Recent Developments/Updates
7.17.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.18 Biogen
7.18.1 Biogen Details
7.18.2 Biogen Major Business
7.18.3 Biogen Solid Dosage Form Drug Product and Services
7.18.4 Biogen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Biogen Recent Developments/Updates
7.18.6 Biogen Competitive Strengths & Weaknesses
7.19 Astellas
7.19.1 Astellas Details
7.19.2 Astellas Major Business
7.19.3 Astellas Solid Dosage Form Drug Product and Services
7.19.4 Astellas Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Astellas Recent Developments/Updates
7.19.6 Astellas Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Solid Dosage Form Drug Industry Chain
8.2 Solid Dosage Form Drug Upstream Analysis
8.3 Solid Dosage Form Drug Midstream Analysis
8.4 Solid Dosage Form Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Solid Dosage Form Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Solid Dosage Form Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Solid Dosage Form Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Solid Dosage Form Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Solid Dosage Form Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Solid Dosage Form Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Solid Dosage Form Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Solid Dosage Form Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Solid Dosage Form Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Solid Dosage Form Drug Players in 2022
Table 12. World Solid Dosage Form Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Solid Dosage Form Drug Company Evaluation Quadrant
Table 14. Head Office of Key Solid Dosage Form Drug Player
Table 15. Solid Dosage Form Drug Market: Company Product Type Footprint
Table 16. Solid Dosage Form Drug Market: Company Product Application Footprint
Table 17. Solid Dosage Form Drug Mergers & Acquisitions Activity
Table 18. United States VS China Solid Dosage Form Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Solid Dosage Form Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Solid Dosage Form Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Solid Dosage Form Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Solid Dosage Form Drug Revenue Market Share (2018-2023)
Table 23. China Based Solid Dosage Form Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Solid Dosage Form Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Solid Dosage Form Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Solid Dosage Form Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Solid Dosage Form Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Solid Dosage Form Drug Revenue Market Share (2018-2023)
Table 29. World Solid Dosage Form Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Solid Dosage Form Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Solid Dosage Form Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Solid Dosage Form Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Solid Dosage Form Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Solid Dosage Form Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Johnson & Johnson Basic Information, Area Served and Competitors
Table 36. Johnson & Johnson Major Business
Table 37. Johnson & Johnson Solid Dosage Form Drug Product and Services
Table 38. Johnson & Johnson Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Johnson & Johnson Recent Developments/Updates
Table 40. Johnson & Johnson Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Solid Dosage Form Drug Product and Services
Table 44. Novartis Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Roche Basic Information, Area Served and Competitors
Table 48. Roche Major Business
Table 49. Roche Solid Dosage Form Drug Product and Services
Table 50. Roche Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Roche Recent Developments/Updates
Table 52. Roche Competitive Strengths & Weaknesses
Table 53. AbbVie Basic Information, Area Served and Competitors
Table 54. AbbVie Major Business
Table 55. AbbVie Solid Dosage Form Drug Product and Services
Table 56. AbbVie Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. AbbVie Recent Developments/Updates
Table 58. AbbVie Competitive Strengths & Weaknesses
Table 59. Merck & Co. Basic Information, Area Served and Competitors
Table 60. Merck & Co. Major Business
Table 61. Merck & Co. Solid Dosage Form Drug Product and Services
Table 62. Merck & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Merck & Co. Recent Developments/Updates
Table 64. Merck & Co. Competitive Strengths & Weaknesses
Table 65. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 66. Bristol Myers Squibb Major Business
Table 67. Bristol Myers Squibb Solid Dosage Form Drug Product and Services
Table 68. Bristol Myers Squibb Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Bristol Myers Squibb Recent Developments/Updates
Table 70. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 71. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 72. GlaxoSmithKline Major Business
Table 73. GlaxoSmithKline Solid Dosage Form Drug Product and Services
Table 74. GlaxoSmithKline Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. GlaxoSmithKline Recent Developments/Updates
Table 76. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 77. Pfizer Basic Information, Area Served and Competitors
Table 78. Pfizer Major Business
Table 79. Pfizer Solid Dosage Form Drug Product and Services
Table 80. Pfizer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Pfizer Recent Developments/Updates
Table 82. Pfizer Competitive Strengths & Weaknesses
Table 83. Sanofi Basic Information, Area Served and Competitors
Table 84. Sanofi Major Business
Table 85. Sanofi Solid Dosage Form Drug Product and Services
Table 86. Sanofi Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sanofi Recent Developments/Updates
Table 88. Sanofi Competitive Strengths & Weaknesses
Table 89. Takeda Basic Information, Area Served and Competitors
Table 90. Takeda Major Business
Table 91. Takeda Solid Dosage Form Drug Product and Services
Table 92. Takeda Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Takeda Recent Developments/Updates
Table 94. Takeda Competitive Strengths & Weaknesses
Table 95. AstraZeneca Basic Information, Area Served and Competitors
Table 96. AstraZeneca Major Business
Table 97. AstraZeneca Solid Dosage Form Drug Product and Services
Table 98. AstraZeneca Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. AstraZeneca Recent Developments/Updates
Table 100. AstraZeneca Competitive Strengths & Weaknesses
Table 101. Bayer Basic Information, Area Served and Competitors
Table 102. Bayer Major Business
Table 103. Bayer Solid Dosage Form Drug Product and Services
Table 104. Bayer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Bayer Recent Developments/Updates
Table 106. Bayer Competitive Strengths & Weaknesses
Table 107. Eli Lilly & Co. Basic Information, Area Served and Competitors
Table 108. Eli Lilly & Co. Major Business
Table 109. Eli Lilly & Co. Solid Dosage Form Drug Product and Services
Table 110. Eli Lilly & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Eli Lilly & Co. Recent Developments/Updates
Table 112. Eli Lilly & Co. Competitive Strengths & Weaknesses
Table 113. Gilead Sciences Basic Information, Area Served and Competitors
Table 114. Gilead Sciences Major Business
Table 115. Gilead Sciences Solid Dosage Form Drug Product and Services
Table 116. Gilead Sciences Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Gilead Sciences Recent Developments/Updates
Table 118. Gilead Sciences Competitive Strengths & Weaknesses
Table 119. Amgen Basic Information, Area Served and Competitors
Table 120. Amgen Major Business
Table 121. Amgen Solid Dosage Form Drug Product and Services
Table 122. Amgen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Amgen Recent Developments/Updates
Table 124. Amgen Competitive Strengths & Weaknesses
Table 125. Teva Basic Information, Area Served and Competitors
Table 126. Teva Major Business
Table 127. Teva Solid Dosage Form Drug Product and Services
Table 128. Teva Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Teva Recent Developments/Updates
Table 130. Teva Competitive Strengths & Weaknesses
Table 131. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 132. Boehringer Ingelheim Major Business
Table 133. Boehringer Ingelheim Solid Dosage Form Drug Product and Services
Table 134. Boehringer Ingelheim Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Boehringer Ingelheim Recent Developments/Updates
Table 136. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 137. Biogen Basic Information, Area Served and Competitors
Table 138. Biogen Major Business
Table 139. Biogen Solid Dosage Form Drug Product and Services
Table 140. Biogen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Biogen Recent Developments/Updates
Table 142. Astellas Basic Information, Area Served and Competitors
Table 143. Astellas Major Business
Table 144. Astellas Solid Dosage Form Drug Product and Services
Table 145. Astellas Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of Solid Dosage Form Drug Upstream (Raw Materials)
Table 147. Solid Dosage Form Drug Typical Customers
Table 1. World Solid Dosage Form Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Solid Dosage Form Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Solid Dosage Form Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Solid Dosage Form Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Solid Dosage Form Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Solid Dosage Form Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Solid Dosage Form Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Solid Dosage Form Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Solid Dosage Form Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Solid Dosage Form Drug Players in 2022
Table 12. World Solid Dosage Form Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Solid Dosage Form Drug Company Evaluation Quadrant
Table 14. Head Office of Key Solid Dosage Form Drug Player
Table 15. Solid Dosage Form Drug Market: Company Product Type Footprint
Table 16. Solid Dosage Form Drug Market: Company Product Application Footprint
Table 17. Solid Dosage Form Drug Mergers & Acquisitions Activity
Table 18. United States VS China Solid Dosage Form Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Solid Dosage Form Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Solid Dosage Form Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Solid Dosage Form Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Solid Dosage Form Drug Revenue Market Share (2018-2023)
Table 23. China Based Solid Dosage Form Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Solid Dosage Form Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Solid Dosage Form Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Solid Dosage Form Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Solid Dosage Form Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Solid Dosage Form Drug Revenue Market Share (2018-2023)
Table 29. World Solid Dosage Form Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Solid Dosage Form Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Solid Dosage Form Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Solid Dosage Form Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Solid Dosage Form Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Solid Dosage Form Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Johnson & Johnson Basic Information, Area Served and Competitors
Table 36. Johnson & Johnson Major Business
Table 37. Johnson & Johnson Solid Dosage Form Drug Product and Services
Table 38. Johnson & Johnson Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Johnson & Johnson Recent Developments/Updates
Table 40. Johnson & Johnson Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Solid Dosage Form Drug Product and Services
Table 44. Novartis Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Roche Basic Information, Area Served and Competitors
Table 48. Roche Major Business
Table 49. Roche Solid Dosage Form Drug Product and Services
Table 50. Roche Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Roche Recent Developments/Updates
Table 52. Roche Competitive Strengths & Weaknesses
Table 53. AbbVie Basic Information, Area Served and Competitors
Table 54. AbbVie Major Business
Table 55. AbbVie Solid Dosage Form Drug Product and Services
Table 56. AbbVie Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. AbbVie Recent Developments/Updates
Table 58. AbbVie Competitive Strengths & Weaknesses
Table 59. Merck & Co. Basic Information, Area Served and Competitors
Table 60. Merck & Co. Major Business
Table 61. Merck & Co. Solid Dosage Form Drug Product and Services
Table 62. Merck & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Merck & Co. Recent Developments/Updates
Table 64. Merck & Co. Competitive Strengths & Weaknesses
Table 65. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 66. Bristol Myers Squibb Major Business
Table 67. Bristol Myers Squibb Solid Dosage Form Drug Product and Services
Table 68. Bristol Myers Squibb Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Bristol Myers Squibb Recent Developments/Updates
Table 70. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 71. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 72. GlaxoSmithKline Major Business
Table 73. GlaxoSmithKline Solid Dosage Form Drug Product and Services
Table 74. GlaxoSmithKline Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. GlaxoSmithKline Recent Developments/Updates
Table 76. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 77. Pfizer Basic Information, Area Served and Competitors
Table 78. Pfizer Major Business
Table 79. Pfizer Solid Dosage Form Drug Product and Services
Table 80. Pfizer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Pfizer Recent Developments/Updates
Table 82. Pfizer Competitive Strengths & Weaknesses
Table 83. Sanofi Basic Information, Area Served and Competitors
Table 84. Sanofi Major Business
Table 85. Sanofi Solid Dosage Form Drug Product and Services
Table 86. Sanofi Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sanofi Recent Developments/Updates
Table 88. Sanofi Competitive Strengths & Weaknesses
Table 89. Takeda Basic Information, Area Served and Competitors
Table 90. Takeda Major Business
Table 91. Takeda Solid Dosage Form Drug Product and Services
Table 92. Takeda Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Takeda Recent Developments/Updates
Table 94. Takeda Competitive Strengths & Weaknesses
Table 95. AstraZeneca Basic Information, Area Served and Competitors
Table 96. AstraZeneca Major Business
Table 97. AstraZeneca Solid Dosage Form Drug Product and Services
Table 98. AstraZeneca Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. AstraZeneca Recent Developments/Updates
Table 100. AstraZeneca Competitive Strengths & Weaknesses
Table 101. Bayer Basic Information, Area Served and Competitors
Table 102. Bayer Major Business
Table 103. Bayer Solid Dosage Form Drug Product and Services
Table 104. Bayer Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Bayer Recent Developments/Updates
Table 106. Bayer Competitive Strengths & Weaknesses
Table 107. Eli Lilly & Co. Basic Information, Area Served and Competitors
Table 108. Eli Lilly & Co. Major Business
Table 109. Eli Lilly & Co. Solid Dosage Form Drug Product and Services
Table 110. Eli Lilly & Co. Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Eli Lilly & Co. Recent Developments/Updates
Table 112. Eli Lilly & Co. Competitive Strengths & Weaknesses
Table 113. Gilead Sciences Basic Information, Area Served and Competitors
Table 114. Gilead Sciences Major Business
Table 115. Gilead Sciences Solid Dosage Form Drug Product and Services
Table 116. Gilead Sciences Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Gilead Sciences Recent Developments/Updates
Table 118. Gilead Sciences Competitive Strengths & Weaknesses
Table 119. Amgen Basic Information, Area Served and Competitors
Table 120. Amgen Major Business
Table 121. Amgen Solid Dosage Form Drug Product and Services
Table 122. Amgen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Amgen Recent Developments/Updates
Table 124. Amgen Competitive Strengths & Weaknesses
Table 125. Teva Basic Information, Area Served and Competitors
Table 126. Teva Major Business
Table 127. Teva Solid Dosage Form Drug Product and Services
Table 128. Teva Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Teva Recent Developments/Updates
Table 130. Teva Competitive Strengths & Weaknesses
Table 131. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 132. Boehringer Ingelheim Major Business
Table 133. Boehringer Ingelheim Solid Dosage Form Drug Product and Services
Table 134. Boehringer Ingelheim Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Boehringer Ingelheim Recent Developments/Updates
Table 136. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 137. Biogen Basic Information, Area Served and Competitors
Table 138. Biogen Major Business
Table 139. Biogen Solid Dosage Form Drug Product and Services
Table 140. Biogen Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Biogen Recent Developments/Updates
Table 142. Astellas Basic Information, Area Served and Competitors
Table 143. Astellas Major Business
Table 144. Astellas Solid Dosage Form Drug Product and Services
Table 145. Astellas Solid Dosage Form Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of Solid Dosage Form Drug Upstream (Raw Materials)
Table 147. Solid Dosage Form Drug Typical Customers
LIST OF FIGURES
Figure 1. Solid Dosage Form Drug Picture
Figure 2. World Solid Dosage Form Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Solid Dosage Form Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Solid Dosage Form Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Solid Dosage Form Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 13. Solid Dosage Form Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Solid Dosage Form Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Solid Dosage Form Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Solid Dosage Form Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Solid Dosage Form Drug Markets in 2022
Figure 27. United States VS China: Solid Dosage Form Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Solid Dosage Form Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Solid Dosage Form Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Solid Dosage Form Drug Market Size Market Share by Type in 2022
Figure 31. Tablet
Figure 32. Capsules
Figure 33. Other
Figure 34. World Solid Dosage Form Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Solid Dosage Form Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Solid Dosage Form Drug Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Retail Pharmacy
Figure 39. Other
Figure 40. Solid Dosage Form Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Solid Dosage Form Drug Picture
Figure 2. World Solid Dosage Form Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Solid Dosage Form Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Solid Dosage Form Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Solid Dosage Form Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Solid Dosage Form Drug Revenue (2018-2029) & (USD Million)
Figure 13. Solid Dosage Form Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Solid Dosage Form Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Solid Dosage Form Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Solid Dosage Form Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Solid Dosage Form Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Solid Dosage Form Drug Markets in 2022
Figure 27. United States VS China: Solid Dosage Form Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Solid Dosage Form Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Solid Dosage Form Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Solid Dosage Form Drug Market Size Market Share by Type in 2022
Figure 31. Tablet
Figure 32. Capsules
Figure 33. Other
Figure 34. World Solid Dosage Form Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Solid Dosage Form Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Solid Dosage Form Drug Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Retail Pharmacy
Figure 39. Other
Figure 40. Solid Dosage Form Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
